R. F. Newbold

919 total citations
18 papers, 760 citations indexed

About

R. F. Newbold is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, R. F. Newbold has authored 18 papers receiving a total of 760 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Physiology and 3 papers in Oncology. Recurrent topics in R. F. Newbold's work include Telomeres, Telomerase, and Senescence (10 papers), Epigenetics and DNA Methylation (5 papers) and Cancer Research and Treatments (3 papers). R. F. Newbold is often cited by papers focused on Telomeres, Telomerase, and Senescence (10 papers), Epigenetics and DNA Methylation (5 papers) and Cancer Research and Treatments (3 papers). R. F. Newbold collaborates with scholars based in United Kingdom, Switzerland and Brunei. R. F. Newbold's co-authors include Kefah Mokbel, Wen G. Jiang, Timothy Roberts, W Al Sarakbi, Walid Sasi, Jacquelyn Bond, Eric Kenneth Parkinson, Enrique Samper, Predrag Slijepčević and Simon Bouffler and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Cancer Research and Oncogene.

In The Last Decade

R. F. Newbold

18 papers receiving 747 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. F. Newbold United Kingdom	12	533	329	157	100	97	18	760
Noriyuki Yatabe Japan	11	416 0.8×	348 1.1×	115 0.7×	125 1.3×	119 1.2×	12	827
Tara M. Lichtenberg United States	3	346 0.6×	245 0.7×	150 1.0×	88 0.9×	193 2.0×	7	635
Colleen Fordyce United States	16	383 0.7×	216 0.7×	199 1.3×	105 1.1×	156 1.6×	18	681
Hongyu Deng China	10	505 0.9×	251 0.8×	88 0.6×	65 0.7×	211 2.2×	36	669
Meta W. Djojosubroto Germany	7	402 0.8×	357 1.1×	123 0.8×	56 0.6×	58 0.6×	8	680
Virginie Mougey France	7	344 0.6×	197 0.6×	211 1.3×	50 0.5×	78 0.8×	13	599
Yi Young Choi South Korea	18	460 0.9×	247 0.8×	107 0.7×	48 0.5×	201 2.1×	26	712
Abdul M. Mondal United States	10	396 0.7×	153 0.5×	287 1.8×	23 0.2×	114 1.2×	13	664
Aaheli Roy Choudhury Germany	6	309 0.6×	239 0.7×	94 0.6×	32 0.3×	77 0.8×	7	518
B. C. Giovanella United States	9	635 1.2×	105 0.3×	569 3.6×	101 1.0×	164 1.7×	12	874

Countries citing papers authored by R. F. Newbold

Since Specialization

Citations

This map shows the geographic impact of R. F. Newbold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. F. Newbold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. F. Newbold more than expected).

Fields of papers citing papers by R. F. Newbold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. F. Newbold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. F. Newbold. The network helps show where R. F. Newbold may publish in the future.

Co-authorship network of co-authors of R. F. Newbold

This figure shows the co-authorship network connecting the top 25 collaborators of R. F. Newbold. A scholar is included among the top collaborators of R. F. Newbold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. F. Newbold. R. F. Newbold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Wazir, Umar, R. F. Newbold, Wen G. Jiang, Anup Sharma, & Kefah Mokbel. (2013). Prognostic and therapeutic implications of mTORC1 and Rictor expression in human breast cancer. Oncology Reports. 29(5). 1969–1974. 34 indexed citations

Patani, Neill, Wen G. Jiang, R. F. Newbold, & Kefah Mokbel. (2011). P1-05-05: Prognostic Utility of Histone Modifier Gene Expression Profiles in Human Breast Cancer.. Cancer Research. 71(24_Supplement). P1–5. 1 indexed citations

Sarakbi, Wail Al, et al.. (2010). Evidence of a tumour suppressor function for DLEC1 in human breast cancer.. PubMed. 30(4). 1079–82. 8 indexed citations

Sarakbi, W Al, Walid Sasi, Wen G. Jiang, et al.. (2009). The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters. BMC Cancer. 9(1). 290–290. 98 indexed citations

Jiang, Wen G., et al.. (2008). Evidence of a tumour suppressive function of E2F1 gene in human breast cancer.. PubMed. 28(4B). 2135–9. 26 indexed citations

Jiang, Wen G., et al.. (2007). hTERT mRNA expression is associated with a poor clinical outcome in human breast cancer.. PubMed. 26(6C). 4901–4. 22 indexed citations

Roberts, Timothy, et al.. (2005). WNT5A expression in human breast cancer.. PubMed. 25(2A). 731–4. 70 indexed citations

Roberts, Timothy, et al.. (2005). Evidence for a Tumour Suppressive Function of APRG1 in Breast Cancer. Breast Cancer Research and Treatment. 93(2). 97–100. 5 indexed citations

Kirkpatrick, Katharine, et al.. (2002). Telomerase activity and Bcl-2 expression in human breast cancer. European Journal of Surgical Oncology. 28(1). 14–18. 7 indexed citations

10.

Newbold, R. F.. (2002). The significance of telomerase activation and cellular immortalization in human cancer. Mutagenesis. 17(6). 539–550. 62 indexed citations

11.

McIlrath, Joanne, Simon Bouffler, Enrique Samper, et al.. (2001). Telomere length abnormalities in mammalian radiosensitive cells.. PubMed. 61(3). 912–5. 128 indexed citations

12.

Mokbel, Kefah, et al.. (2000). Telomerase activity and lymphovascular invasion in breast cancer. European Journal of Surgical Oncology. 26(1). 30–33. 37 indexed citations

13.

Mokbel, Kefah, et al.. (2000). The association between telomerase activity and hormone receptor status and p53 expression in breast cancer.. PubMed. 1(6). 509–16. 18 indexed citations

14.

Newbold, R. F.. (1999). Chaos Theory in Nonnus' 'Dionysiaca'. Adelaide Research & Scholarship (AR&S) (University of Adelaide). 8. 37. 1 indexed citations

15.

Bond, Jacquelyn, et al.. (1999). Telomerase Repressor Sequences on Chromosome 3 and Induction of Permanent Growth Arrest in Human Breast Cancer Cells. JNCI Journal of the National Cancer Institute. 91(1). 37–45. 99 indexed citations

16.

Newbold, R. F.. (1999). Telomerase as an anti-cancer drug target: will it fulfil its early promise?. PubMed. 14(4). 349–54. 8 indexed citations

17.

Loughran, Öonagh, Louise Clark, Jacquelyn Bond, et al.. (1997). Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes. Oncogene. 14(16). 1955–1964. 65 indexed citations

18.

Ekong, Rosemary, et al.. (1995). Construction and characterization of a highly stable human:rodent monochromosomal hybrid panel for genetic complementation and genome mapping studies. Cytogenetic and Genome Research. 71(1). 68–76. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact